Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study

ConclusionPatients previously treated with benznidazole had significantly reduced parasitemia, a lower prevalence of markers of severe cardiomyopathy, and lower mortality after two years of follow-up. If used in the early phases, benznidazole treatment may improve clinical and parasitological outcomes in patients with chronic ChD. Trial registrationClinicalTrials.gov, Trial registration: NCT02646943.
Source: PLoS Neglected Tropical Diseases - Category: Tropical Medicine Authors: Source Type: research